Gateway 2012: Hamilton Company - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Hamilton Company


Hamilton Company
4970 Energy Way
Reno, NV 89502
Contact: Amber Ratcliff / Marketing Manager
Phone: 800-648-5950
URL: www.hamiltoncompany.com/Sensors

Company Description:

Hamilton Company is a global enterprise with manufacturing facilities in Reno, Nevada and Bonaduz, Switzerland. We are the worldwide leader in the design and manufacturing of manual, semi-automated, and robotic products for liquid handling as well as analytical detection. We offer a complete line of high quality pH, redox, conductivity, and oxygen electrodes for laboratory and process measurement. For over 50 years, we’ve been satisfying customers by combining quality materials with skilled workmanship, ensuring the highest level of performance to every device we manufacture. Hamilton’s lifelong commitment to accuracy and quality has earned us a global ISO 9001 certification.

INTERPHEX 2012 Booth Preview:

Hamilton Company manufactures application-oriented pH, ORP, dissolved oxygen, and conductivity sensors distinguished by their high quality, long life, and competitive price. Our intelligent VISIFERM optical dissolved oxygen probe offers technology that sets new standards in DO measurement. The new Hamilton ARC revolutionizes process analytics by replacing the traditional transmitter with a microprocessor within the sensor. ARC sensors measure more reliably as well as save on cost because they communicate directly with the process control system. Stop by our INTERPHEX 2012 booth # 3564 to discover more innovations from Hamilton.

Online PDF Documents:
Hamilton ARC Catalog
Hamilton Process Sensors Catalog

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
FindPharma Custom Search

Click here